Senior Director, Investor Relations

NanoString Technologies
Job Location
530 Fairview Ave N
Seattle, WA 98109
Competitive Comp

Stock Options, ESPP, Matching 401K, PTO, and more...

Job Description

This individual will serve as the company’s Investor Relations Officer and head of Investor Relations and will be the primary person to direct NanoString's interactions and communications with all existing and potential shareholders. The Senior Director of Investor Relations will work closely with the CEO and CFO and align with other internal management partners to communicate the company’s strategic, commercial and financial objectives to the broader investment community and relay feedback from investors as to the perception of the company’s performance and strategy.


  • Primary point of contact for Wall Street, including institutional investors, individual investors, sell-side analysts, exchange representatives
  • Direct ongoing dialogue with investment community
  • Collaborate with CEO, CFO, senior executives to devise external communication strategy relating to material corporate actions (earnings, guidance, strategic transactions, etc.)
  • Collaborate with marketing and commercial organization to communicate product and market strategy to wall street
  • Manage relationships and coordinate activities of outside IR and PR consultants
  • Manage quarterly earnings calls including writing of earnings release, conference call script, management Q&As
  • Manage and monitor investment research on the company and industry peers
  • Maintain and communicate competitive intelligence and analysis on all industry peers to senior management
  • Convey sentiment and feedback from investment community to senior management
  • Manage company’s participation in investment conferences including preparation of external presentations and designation of 1on1 meetings
  • Manage company’s quarterly non-deal road show activities including all geographic and account specific targeting, presentations and utilization of the sell-side
  • Organize and manage analyst targeted events including Analyst/R&D day, bus tours, etc.
  • Maintain wall street consensus model
  • Manage Investor Relations portion of the company website
  • Provide Regulation FD and general communications training to all designated company spokespersons
  • Other Investor Relations and Corporate Communications activities as appropriate
  • 10 years experience in investor relations, finance and investments, Life Sciences, Diagnostic, or Medical Device industry (Must have)
  • Education: BA/BS, Masters of Business Administration
  • Molecular biology, chemistry, genetics, engineering or Wall Street backgrounds a plus
  • Strong interpersonal skills and ability to develop relationships with the investment community
  • Exceptional oral and written communication and presentation skills
  • Demonstrated ability and experience in effectively collaborating with executives and senior leaders
  • Demonstrated leadership skills and experience
  • Must thrive in a dynamic, fast-paced environment
  • Must be willing to travel 50% of the time
About Our Organization

NanoString Technologies (NASDAQ:“NSTG”) provides life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 450 peer-reviewed publications, has also now been applied to diagnostic use as the nCounter Dx Analysis System. The company's technology offers a cost-effective way to easily profile the expression of hundreds of genes, miRNAs, or copy number variations, simultaneously with high sensitivity, reproducibility and precision. The company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The nCounter-based Prosigna™ Breast Cancer Prognostic Gene Signature Assay is the first in vitro diagnostic kit to be marketed through the company's diagnostics business. Leveraging the company’s innovative platform and proven development, regulatory and commercial expertise , NanoString has established a companion diagnostics capability to enable biopharmaceuticals partners to translate biomarker discoveries into clinically-relevant diagnostics, helping to bring the right therapy to the right patient at the right time.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.